Riskpilot← Back to searchSign inGet full accessIKAST FYSIOTERAPI I ApS
APSActiveCVR 36476834Brogårdvej 57Physiotherapy activities · NACE 8695Est. 2014— employees
Revenue 2024
—
EBITDA margin
—
+14% vs 2023
Equity ratio
83.1%
Financial strength
Net profit 2024
DKK 1M
+15% vs 2023
| Revenue | — | — |
| EBITDA | DKK 1,2M | +14% |
| Net profit | DKK 1M | +15% |
| Total assets | DKK 2,2M | +22% |
| Equity | DKK 1,8M | +21% |
| Employees | — | — |
Legal name
IKAST FYSIOTERAPI I ApS
CVR number
36476834
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
29. december 2014
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive fysioterapiklinik, herunder at deltaget i interessentskaber der driver fysioterapiklinik samt dermed beslægtet virksomhed.
Address
Brogårdvej 57
Email
jensoleleth@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 507 | 1.054 | 1.184 | 1.097 | 1.250 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 507 | 1.054 | 1.184 | 1.097 | 1.250 |
| Net financials | 516 | 1.063 | 1.211 | 1.148 | 1.313 |
| Profit before tax | 504 | 1.050 | 1.189 | 1.135 | 1.300 |
| Tax | 111 | 232 | 262 | 250 | 286 |
| Net profit | 392 | 818 | 927 | 885 | 1.014 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 550 | 1.230 | 1.571 | 1.759 | 2.151 |
| Equity | 442 | 960 | 1.288 | 1.473 | 1.787 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 86 | 259 | 283 | 247 | 332 |
| Total debt | 86 | 259 | 283 | 247 | 332 |
EBITDA margin
124997900.0%
This company
15.8%
Market median
+791125849% vs market
20202024
Equity ratio
83.1%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
56.7%
This company
18.4%
Market median
+208% vs market
20202024
Net profit margin
101414500.0%
This company
8.1%
Market median
+1252030764% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Management | Management | 2020 |
| Former (3) | ||
HØ Management | Management | 2014 – 2018 |
KE Management | Management | 2018 – 2020 |
KM Management | Management | 2018 – 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2026 | |
| Company | 50–66.65% | 50–66.65% | 2018 | |
| Company | 50–66.65% | 50–66.65% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Jens Ole LS Holding ApS
IKAST FYSIOTERAPI I ApS Board members of IKAST FYSIOTERAPI I ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanne Øxenbjerg | Management | 0 companies |
| Karen Elisabeth Østergaard Nissen | Management | 0 companies |
| Jens Ole Leth Staunstrup | Management | 0 companies |
| Kathrine Marie Philipsen | Management | 0 companies |